NO20021734L - Fiskefôr med okt nukelotidinnhold - Google Patents
Fiskefôr med okt nukelotidinnhold Download PDFInfo
- Publication number
- NO20021734L NO20021734L NO20021734A NO20021734A NO20021734L NO 20021734 L NO20021734 L NO 20021734L NO 20021734 A NO20021734 A NO 20021734A NO 20021734 A NO20021734 A NO 20021734A NO 20021734 L NO20021734 L NO 20021734L
- Authority
- NO
- Norway
- Prior art keywords
- nucleotides
- fish
- nucleotide
- additives
- diet
- Prior art date
Links
- 239000002773 nucleotide Substances 0.000 title claims abstract description 56
- 125000003729 nucleotide group Chemical group 0.000 title claims abstract description 55
- 241000251468 Actinopterygii Species 0.000 claims abstract description 30
- 235000005911 diet Nutrition 0.000 claims abstract description 30
- 230000037213 diet Effects 0.000 claims abstract description 30
- 239000000049 pigment Substances 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 18
- 239000000654 additive Substances 0.000 claims abstract description 13
- 210000001035 gastrointestinal tract Anatomy 0.000 claims abstract description 12
- 239000000203 mixture Substances 0.000 claims abstract description 11
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims abstract description 10
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 claims abstract description 10
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims abstract description 10
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 claims abstract description 10
- 230000000968 intestinal effect Effects 0.000 claims abstract description 9
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229930024421 Adenine Natural products 0.000 claims abstract description 5
- 229960000643 adenine Drugs 0.000 claims abstract description 5
- 229940104302 cytosine Drugs 0.000 claims abstract description 5
- 229940113082 thymine Drugs 0.000 claims abstract description 5
- 229940035893 uracil Drugs 0.000 claims abstract description 5
- 238000010521 absorption reaction Methods 0.000 claims description 10
- 235000013372 meat Nutrition 0.000 claims description 6
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims description 5
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims description 5
- 229940022405 astaxanthin Drugs 0.000 claims description 5
- 235000013793 astaxanthin Nutrition 0.000 claims description 5
- 239000001168 astaxanthin Substances 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 239000003242 anti bacterial agent Substances 0.000 claims description 3
- 229940088710 antibiotic agent Drugs 0.000 claims description 3
- 229960005486 vaccine Drugs 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 230000031891 intestinal absorption Effects 0.000 claims 2
- 230000003278 mimic effect Effects 0.000 claims 1
- 238000004040 coloring Methods 0.000 abstract description 4
- 235000015097 nutrients Nutrition 0.000 abstract description 3
- 239000003674 animal food additive Substances 0.000 abstract 1
- 230000003190 augmentative effect Effects 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 239000002778 food additive Substances 0.000 abstract 1
- 239000013589 supplement Substances 0.000 description 7
- 238000007792 addition Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 230000008021 deposition Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010059017 Intestinal mass Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000020940 control diet Nutrition 0.000 description 1
- 235000007882 dietary composition Nutrition 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000000576 supplementary effect Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- -1 vaccines Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/153—Nucleic acids; Hydrolysis products or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/13—Nucleic acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/805—Pet food for dog, cat, bird, or fish
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Molecular Biology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Insects & Arthropods (AREA)
- Marine Sciences & Fisheries (AREA)
- Mycology (AREA)
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- General Preparation And Processing Of Foods (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9924096.2A GB9924096D0 (en) | 1999-10-13 | 1999-10-13 | Supplement |
| GB0009853A GB0009853D0 (en) | 2000-04-25 | 2000-04-25 | Supplement |
| PCT/GB2000/003899 WO2001026481A1 (en) | 1999-10-13 | 2000-10-11 | Fish feed with increased nucleotide content |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20021734D0 NO20021734D0 (no) | 2002-04-12 |
| NO20021734L true NO20021734L (no) | 2002-04-12 |
Family
ID=26244146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20021734A NO20021734L (no) | 1999-10-13 | 2002-04-12 | Fiskefôr med okt nukelotidinnhold |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6987095B1 (de) |
| EP (2) | EP2050344A1 (de) |
| JP (1) | JP2003511051A (de) |
| AT (1) | ATE431080T1 (de) |
| AU (1) | AU770961B2 (de) |
| CA (1) | CA2382636C (de) |
| CL (1) | CL2009000183A1 (de) |
| DE (1) | DE60042211D1 (de) |
| NO (1) | NO20021734L (de) |
| NZ (1) | NZ518305A (de) |
| WO (1) | WO2001026481A1 (de) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO339169B1 (no) * | 2008-04-24 | 2016-11-14 | Chemoforma Ltd | Funksjonelt fiskefôr omfattende peptidoglykan og nukleotider |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0218932D0 (en) * | 2002-08-14 | 2002-09-25 | Zoolife Internat Ltd | Composition for dietary enrichment |
| CL2008000419A1 (es) | 2007-02-08 | 2008-10-17 | Ewos Innovation As | Uso de una composicion alimenticia para mejorar el bienestar del pez, viabilidad o recuperacion mas rapida, y/o para la prevencion, alivio y/o tratamiento de salmonidos infectados con la enfermedad del pancreas; y composcion alimenticia para salmonid |
| CN101820773A (zh) * | 2007-08-29 | 2010-09-01 | 马斯公司 | 单包猫粮产品及其制造方法 |
| JP6862541B2 (ja) * | 2017-04-28 | 2021-04-21 | 国立大学法人高知大学 | 水棲動物用飼料 |
| JP7471648B2 (ja) * | 2020-10-27 | 2024-04-22 | 獣医医療開発株式会社 | 魚類用薬剤組成物および魚類用薬用飼料 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5712972A (en) | 1980-06-23 | 1982-01-22 | Takeda Chem Ind Ltd | Preparation of food product containing 5"-nucleotide |
| JPS60126220A (ja) * | 1983-12-09 | 1985-07-05 | Otsuka Pharmaceut Factory Inc | 核酸成分組成物 |
| JPS6229530A (ja) | 1985-07-31 | 1987-02-07 | Nisshin Flour Milling Co Ltd | ウナギの鰓病薬 |
| JPH03164140A (ja) * | 1989-11-21 | 1991-07-16 | Sanyo Kokusaku Pulp Co Ltd | 養魚用飼料組成物 |
| JP2756907B2 (ja) | 1993-12-28 | 1998-05-25 | 日本製紙株式会社 | 酵母エキス組成物及びその製造法並びにそれを含有する飼料 |
| JPH07231755A (ja) * | 1994-02-24 | 1995-09-05 | Kohjin Co Ltd | 赤色肉魚類用肉色改善飼料と赤色肉魚類の養殖方法 |
| US5871751A (en) * | 1994-10-12 | 1999-02-16 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Renibacterium salmoninarum vaccine and method for its preparation |
| US5776490A (en) * | 1996-01-26 | 1998-07-07 | The Center For Innovative Technology | Complex protein-walled microcapsules containing lipid-walled microcapsules and method for producing same |
| EP0923312A1 (de) * | 1996-04-29 | 1999-06-23 | K.U. Leuven Research & Development | Hocheffizientes orales verabreichungssystem und verfahren zur herstellung desselben |
-
2000
- 2000-10-11 US US10/110,842 patent/US6987095B1/en not_active Expired - Lifetime
- 2000-10-11 AT AT00966321T patent/ATE431080T1/de not_active IP Right Cessation
- 2000-10-11 AU AU76762/00A patent/AU770961B2/en not_active Ceased
- 2000-10-11 CA CA2382636A patent/CA2382636C/en not_active Expired - Lifetime
- 2000-10-11 JP JP2001529280A patent/JP2003511051A/ja active Pending
- 2000-10-11 EP EP08018053A patent/EP2050344A1/de not_active Withdrawn
- 2000-10-11 EP EP00966321A patent/EP1220617B1/de not_active Revoked
- 2000-10-11 NZ NZ518305A patent/NZ518305A/en unknown
- 2000-10-11 DE DE60042211T patent/DE60042211D1/de not_active Expired - Fee Related
- 2000-10-11 WO PCT/GB2000/003899 patent/WO2001026481A1/en active IP Right Grant
-
2002
- 2002-04-12 NO NO20021734A patent/NO20021734L/no not_active Application Discontinuation
-
2009
- 2009-01-28 CL CL2009000183A patent/CL2009000183A1/es unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO339169B1 (no) * | 2008-04-24 | 2016-11-14 | Chemoforma Ltd | Funksjonelt fiskefôr omfattende peptidoglykan og nukleotider |
Also Published As
| Publication number | Publication date |
|---|---|
| AU7676200A (en) | 2001-04-23 |
| NO20021734D0 (no) | 2002-04-12 |
| AU770961B2 (en) | 2004-03-11 |
| DE60042211D1 (de) | 2009-06-25 |
| WO2001026481A1 (en) | 2001-04-19 |
| EP1220617B1 (de) | 2009-05-13 |
| ATE431080T1 (de) | 2009-05-15 |
| CA2382636A1 (en) | 2001-04-19 |
| US6987095B1 (en) | 2006-01-17 |
| CL2009000183A1 (es) | 2009-05-22 |
| NZ518305A (en) | 2004-08-27 |
| EP2050344A1 (de) | 2009-04-22 |
| CA2382636C (en) | 2011-03-22 |
| JP2003511051A (ja) | 2003-03-25 |
| EP1220617A1 (de) | 2002-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KESHAVARZ et al. | Re-evaluation of calcium and phosphorus requirements of laying hens for optimum performance and eggshell quality | |
| Xu et al. | Effects of dietary yeast nucleotides on growth, non-specific immunity, intestine growth and intestinal microbiota of juvenile hybrid tilapia Oreochromis niloticus♀× Oreochromis aureus♂ | |
| McDevitt et al. | Can betaine partially replace or enhance the effect of methionine by improving broiler growth and carcase characteristics? | |
| Wei et al. | Fish protein hydrolysate affected amino acid absorption and related gene expressions of IGF‐1/AKT pathways in turbot (Scophthalmus maximus) | |
| Ai et al. | Effects of a-ketoglutarate (AKG) supplementation in low phosphorous diets on the growth, phosphorus metabolism and skeletal development of juvenile mirror carp (Cyprinus carpio) | |
| Carlisle | Essentiality and function of silicon | |
| KR100849371B1 (ko) | 가축용 사료 | |
| NO20021734L (no) | Fiskefôr med okt nukelotidinnhold | |
| Reeves et al. | Effects of dietary composition on somatomedin activity in growing rats | |
| CN104939089B (zh) | 具有改善骨密度功能的营养组合物及其制备方法与应用 | |
| CN112515054A (zh) | 一种提高凡纳滨对虾生长性能的低蛋白质饲料及其应用 | |
| Bhagat et al. | The effect of sulphite in solid diets on the growth of rats | |
| Karunajeewa et al. | Effect of dietary phosphorus concentration and electrolyte balance on the growth performance of broiler chickens | |
| AU688435B2 (en) | Pharmaceutical composition for immunomodulating and adjuvant treatment | |
| Aoki et al. | Periodical changes of plasma free amino acid levels and feed digesta in yellowtail after feeding nonfishmeal diets with or without supplemental crystalline amino acids | |
| Muramatsu et al. | Biological efficacy of liquid methionine and methionine hydroxy analogue-free acid in chicks | |
| Davidson et al. | Observations on the utilisation of dietary energy by medium‐and fast‐growing strains of cockerels and on their arginine and methionine requirements | |
| Dunnington et al. | Effects of dietary taurine on growth and Escherichia coli resistance in chickens | |
| Li et al. | Effects of exogenous ghrelin on duodenal growth and development of african ostrich chicks | |
| Liu et al. | Dietary lysine affect carcass characteristics and myostatin gene exon 1 region methylation in muscle tissue of broilers | |
| Trairatapiwan et al. | Effect of nucleotides supplementation on growth performance, humoral immunity, and intestinal morphological structure of broiler chickens | |
| Rahmawati et al. | Protein Mass and Calcium Mass of Broiler Chicken with Added Nucleotides at Different Maintenance Temperatures | |
| RU2195838C2 (ru) | Препарат для стимуляции роста и повышения резистентности сельскохозяйственных, домашних животных и птицы | |
| Abd El Rahman et al. | Dietary Nucleoforce® supplementation improves growth performance, feed efficiency and enhances intestinal morphology in broiler chickens | |
| Nešić et al. | Impact of calcium administered through drinking water on egg production of laying hens |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |